Genetic polymorphisms for the study of multifactorial stroke

Human Mutation

Volumn 29, Issue 6, 2008, Pages 776-795

  Bersano, A ^a   Ballabio, E ^a   Bresolin, N ^a   Candelise, Livia ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Association; Genetic; Hemostasis; Polymorphism; Stroke

Indexed keywords

ACE GENE; AGT GENE; ALOX5AP GENE; APOE GENE; CBS GENE; CEREBROVASCULAR ACCIDENT; F12 GENE; F13A1 GENE; F2 GENE; F5 GENE; F7 GENE; FGB GENE; FGG GENE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRAIT; GENETIC VARIABILITY; GFA GENE; GP1BA GENE; HUMAN; ITGA2B GENE; ITGB3 GENE; LPL GENE; MTHFR GENE; MTR GENE; NOS3 GENE; NUCLEOTIDE SEQUENCE; PDE4D GENE; PLA1 GENE; PLA2 GENE; PON1 GENE; PRIORITY JOURNAL; REVIEW; SERPINE1 GENE; STROKE; VALIDITY; VWF GENE;

EID: 44849105645     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20666     Document Type: Review

References (208)

1. Afshar-Kharghan V, Li C, Khoshnevis-Asl M, Lopez JA. 1999. Kozak sequence polymorphism in the glycoprotein (GP) Ib alpha gene is a major determinant of the plasma membrane levels of the platelet GPIb-IX-V complex. Blood 94:186-191.
2. Agerholm-Larsen B, Tybjaerg-Hansen A, Frikke-Schmidt R, Gronholdt MLM, Jensen G, Nordestgaard BG. 1997. ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease. Ann Intern Med 127:346-355.
3. Akar N, Yilmaz E, Akar E, Deda G, Sipahi T. 2000a. Factor V (His 1299 Arg) in young Turkish patients with cerebral infarct. Haemostasis 30:118-122.
4. Akar N, Akar E, Deda G, Sipahi T. 2000b. No association between Glu/Asp polymorphism of NOS3 gene and ischemic stroke. Neurology 55:460-461.
5. Akar N, Akar E, Yilmaz E, Deda G. 2001. Plasminogen activator inhibitor -1 4G/5G polymorphism in Turkish children with cerebral infarct and effect on factor V 1691 A mutation. J Child Neurol 16:294-295.
6. Alberts MJ. 2003. Stroke genetics update. Stroke 34:342-344.
7. Altmuller J, Palmer LJ, Fischer G, Scherb H, Wjst M. 2001. Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet 69:936-950.
8. Ariyaratnam R, Casas JP, Whittaker J, Smeeth L, Hingorani AD, Sharma P. 2007. Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med 4:e131.
9. Aznar J, Mira Y, Vaya A, Corella D, Ferrando F, Villa P, Estelles A. 2004. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenetic ischemic stroke. Thromb Haemost 91:1031-1034.
10. Bang CO, Park HK, Ahn MY, Shin HK, Hwang KY, Homg SY. 2001. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue type plasminogen activator gene in atherothrombotic stroke. Cerebrovasc Dis 11:294-299.
11. Banerjee I, Gupta V, Ganesh S. 2007. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J Hum Genet 52:205-219.
12. Baum L, Ng HK, Wong KS, Tomlinson B, Rainer TH, Chen X, Cheung WS, Tang J, Tam WW, Goggins W, Tong CS, Chan DK, Thomas GN, Chook P, Woo KS. 2006a. Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke and myocardial infarction. Clin Chem Lab Med 44:274-281.
13. Baum L, Ng HK, Woo KS, Tomlinson B, Rainer TH, Chen X, Cheung WS, Chan DK, Thomas GN, Tong CS, Wong KS. 2006b. Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk. Clin Biochem 39:191-195.
14. Beisiegel U, Weber W, Bengtsson-Olivecrona G. 1991. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci USA 88:8342-8346.
15. Berge E, Haug KB, Charlotte Sandset E, Kristine Haugbro K, Turkovic M, Sandset PM. 2007. The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation. Stroke 38:1069-1071.
16. Berger K, Stogbauer F, Stoll M, Wellmann J, Huge A, Cheng S, Kessler C, John U, Assmann G, Ringelstein EB, Funke H. 2007. The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies. Hum Genet 121:169-178.
17. Bevan S, Porteous L, Sitzer M, Markus HS. 2005. Phosphodiesterase 4D gene, ischemic stroke, and asymptomatic carotid atherosclerosis. Stroke 36:949-953.
18. Bis JC, Smith NL, Psaty BM, Heckbert SR, Edwards KL, Lemaitre RN, Lumley T, Rosendaal FR. 2003. Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients. Am J Hypertens 16:1011-1017.
19. Blake GJ, Schmitz C, Lindpaintner K, Ridker PM. 2001. Mutation in the promoter region of the beta fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. Eur Heart J 22:2262-2266.
20. Boekholdt SM, Bijsterveld NR, Moons AH, Levi M, Buller HR, Peters RJ. 2001. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 104:3063-3068.
21. Boncoraglio GB, Bodini A, Brambilla C, Carriero MR, Ciusani E, Parati EA. 2006. An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke. Cerebrovasc Dis 22:191-195.
22. Bongers TN, de Maat MP, van Goor ML, Bhagwanbali V, van Vliet HH, Gomez Garcia EB, Dippel DW, Leebeek FW. 2006. High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke 37:2672-2677.
23. Bosco P, Gueant-Rodriguez RM, Anello G, Spada R, Romano A, Fajardo A, Caraci F, Ferri R, Gueant JL. 2006. Association of homocysteine (but not of MTHFR 677 C > T, MTR 2756 A > G, MTRR 66 A > G and TCN2 776 C > G) with ischaemic cerebrovascular disease in Sicily. Thromb Haemost 96:154-159.
24. Brenner D, Labreuche J, Poirier O, Cambien F, Amarenco P; GENIC Investigators. 2005. Renin-angiotensin-aldosterone system in brain infarction and vascular death. Ann Neurol 58:131-138.
25. Brophy VH, Ro SK, Rhees BK, Lui LY, Lee JM, Umblas N, Bentley LG, Li J, Cheng S, Browner WS, Erlich HA. 2006. Association of phosphodiesterase 4D polymorphisms with ischemic stroke in a US population stratified by hypertension status. Stroke 37:1385-1390.
26. Buyru N, Altinisik J, Somay G, Ulutin T. 2005. Factor V Leiden mutation in cerebrovascular disease. Clin Appl Thromb Hemost 11:339-342.
27. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. 1992. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644.
28. Carlsson LE, Santoso S, Spitzer C, Kessler C, Greinacher A. 1999. The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patients. Blood 93:3583-3586.
29. Carter AM, Catto AJ, Bamford JM, Grant PJ. 1998. Platelet GPIIIa and GPIb variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscl Thromb Vasc Biol 18:1124-1131.
30. Carter AM, Catto AJ, Grant PJ. 1999a. Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subject with atrial fibrillation. Circulation 99:2423-2426.
31. Carter AM, Catto AJ, Bamford JM, Grant PJ. 1999b. Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke. Stroke 30:2606-2611.
32. Casas JP, Hingorami AD, Bautista LE, Sharma P. 2004. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 61:1652-1662.
33. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. 2005. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 365:224-232.
34. Catto AJ, Carter AM, Stickland M, Bamford JM, Davies JA, Grant PJ. 1997. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease. Thromb Haemost 77:730-734.
35. Catto AJ, Kohler HP, Bannan S, Stickland M, Carter A, Grant PJ. 1998. Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage. Stroke 29:813-816.
36. Chen CH, LO YK, Ke D, Liu CK, Liou CW, Wu HL, Lai ML for the Southern Taiwan Young Stroke study Group. 2004. Platelet glycoprotein I a C807 T, Ib C3550 T, and IIa Pl A2/A1 polymorphisms and ischemic stroke in young Taiwanese. J Neurol Sci 227:1-5.
37. Cheng CH, Eng HL, Chang CJ, Tsai TT, Lai ML, Chen HY, Liu CJ, Lin TM. 2003. 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke. J Lab Clin Med 142:100-105.
38. Chowdhury AH, Yokoyama T, Kokubo Y, Zaman MM, Haque A, Tanaka H. 2001. Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital-based study. J Epidemiol 11:131-138.
39. Christopher R, Kailasanatha KM, Nagaraja D, Tripathi M. 1996. Case-control study of serum a lipoprotein (a) and apolipoprotein A-I and b in stroke in the young. Acta Neurol Scand 94:127-130.
40. Corral J, Gonzaàlez-Conejero R, Iniesta JA, Rivera J, Martinez C, Vincente V. 2000. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica 85:293-297.
41. Croft SA, Hampton KK, Sorrell JA, Steeds RP, Channer KS, Samani NJ, Daly ME. 1999. The GPIa C807 T dimosphism associated with platelet collagen receptor density is not a isk factor for myocardial infarction. Br J Haematol 106:771-776.
42. Dai K, Gao W, Ruan C. 2001. The SmaI polymorphism in the von Willebrand Factor gene associated with acute ischemic stroke. Thromb Res 104:389-395.
43. de Paula Sabino A, Ribeiro DD, Carvalho MG, Cardoso J, Dusse LM, Fernandes AP. 2006. Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients. Blood Coagul Fibrinolysis 17:271-275.
44. Di Castelnuovo A, de Gaetano G, Benedetti Donati M, Iacoviello L. 2001. Platelet glycoprotein receptor IIIa polymorphism PlA2/Pl A2 and coronary risk: a meta-analysis. Thromb Haemost 85:626-633.
45. Dichgans M, Markus HS. 2005. Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke 36:2027-2031.
46. Dichgans M. 2007. Genetics of ischaemic stroke. Lancet Neurol 6:149-161.
47. Dikmen M, Gunes HV, Degirmenci I, Ozdemir G, Basaran A. 2006a. Are the angiotensin-converting enzyme gene and activity risk factors for stroke? Arq Neuropsiquiatr 64:211-216.
48. Dikmen M, Ozbabalik D, Gunes HV, Degirmenci I, Bal C, Ozdemir G, Basaran A. 2006b. Acute stroke in relation to homocysteine and methylenetetrahydrofolate reductase gene polymorphisms. Acta Neurol Scand 113:307-314.
49. Ding J, Nicklas BJ, Fallin MD, de Rekeneire N, Kritchevsky SB, Pahor M, Rodondi N, Li R, Zmuda JM, Harris TB. 2006. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.Am Heart J 152:1109-1115.
50. Dixon RA, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, Gillard JW, Miller DK. 1990. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343:282-284.
51. Doggen CJ, Manger Cats V, Bertina RM, Reitsma PH, Vandenbroucke JP, Rosendaal FR. 1998. A genetic propensity to higher factor VII is not associated with the risk of myocardial infarction in men. Thromb Haemost 80:281-285.
52. Doggen CJ, Bertina RM, Cats VM, Reitsma PH, Rosendaal FR. 1999. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thromb Haemost 82:115-120.
53. den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestion to describe complex mutations: a discussion. Hum Mutat 15:7-12.
54. Eckel RH. 1989. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N Engl Med 320:1060-1067.
55. Elbaz A, Poirier O, Canple S, Chédru F, Cambien F, Amarenco P on behalf of the GENIC investigators. 2000a. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 95:586-591.
56. Elbaz A, Poirier O, Moulin T, Chédru F, Cambien F, Amarenco P on behalf of the GENIC investigators. 2000b. Association between the Glu298Asp polymorphism in the endothelial constitutive nitric oxide synthase gene and brain infarction. Stroke 31:1631-1639.
57. Endler G, Mannhalter C. 2003. Polymorphisms in coagulation factors genes and thier impact on arterial and venous thrombosis. Clinica Chimica Acta 330:31-55.
58. Fidani L, Hattzitolios AI, Coulas A, Savopoulos C, Basayannis C, Kotsis A. 2005. Cholesteryl ester transfer protein Taq I B and lipoprotein lipasi Ser 447Ter gene polymorphisms are not associated with ischaemic stroke in Greek patients. Neurosci Lett 384:102-105.
59. Florvall G, Basu S, Larsson A. 2006. Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men. J Gerontol A Biol Sci Med Sci 61:1262-1266.
60. Flossmann E, Schulz UG, Rothwell PM. 2004. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 35:212-227.
61. Franco RF, Pazin-Filho A, Tavella MH, Simoes MV, Marin-Neto JA, Zago MA. 2000. Factor XIII val34leu and the risk of myocardial infarction. Haematologica 85:67-71.
62. Funk M, Endler G, Lalouschek W, Hsieh K, Schillinger M, Lang W, Mannhalter C. 2006. Factor VII gene haplotypes and risk of ischemic stroke. Clin Chem 52:1190-1192.
63. Gao W, Dai L, Su J, Wang Z, Ruan C. 2004. The frequency of P475S polymorphism in von Willebrand factor-cleaving protease in the Chinese population and its relevance to arterial thrombotic disorders. Thromb Haemost 91:1257-1258.
64. Gao X, Yang H, ZhiPing T. 2006. Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke. Neurosci Lett 398:172-177.
65. Girolami A, Simioni P, Scarano L, Carraro G. 1999. Prothrombin and the prothrombin 20210 G to A polymorphism: thei relationship with hypercoagulability and thrombosis. Blood Rev 13:205-210.
66. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL; American Heart Association/American Stroke Association Stroke Council; Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; Quality of Care and Outcomes Research Interdisciplinary Working Group; American Academy of Neurology. 2006. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 37:1583-1633.
67. Gonzalez-Conejero R, Fernandez-Cadenas I, Iniesta JA, Marti-Fabregas J, Obach V, Alvarez-Sabin J, Vicente V, Corral J, Montaner J; Proyecto Ictus Research Group. 2006. Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients. Stroke 37:2288-2293.
68. Gormley K, Bevan S, Markus HS. 2007. Polymorphisms in genes of the renin-angiotensin system and cerebral small vessel disease. Cerebrovasc Dis 23:148-155.
69. Gretarsdottir S, Sveinbjornsdottir S, Jonsson HH, Jakobsson F, Einarsdottir E, Agnarsson U, Shkolny D, Einarsson G, Gudjonsdottir HM, Valdimarsson EM, Einarsson OB, Thorgeirsson G, Hadzic R, Jonsdottir S, Reynisdottir ST, Bjarnadottir SM, Gudmundsdottir T, Gudlaugsdottir GJ, Gill R, Lindpaintner K, Sainz J, Hannesson HH, Sigurdsson GT, Frigge ML, Kong A, Gudnason V, Stefansson K, Gulcher JR. 2002. Localization of a susceptibility gene for common forms of stroke to 5q12 Am J Hum Genet 70:593-603.
70. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, Jonsdottir T, Gudmundsdottir T, Bjarnadottir SM, Einarsson OB, Gudjonsdottir HM, Hawkins M, Gudmundsson G, Gudmundsdottir H, Andrason H, Gudmundsdottir AS, Sigurdardottir M, Chou TT, Nahmias J, Goss S, Sveinbjornsdottir S, Valdimarsson EM, Jakobsson F, Agnarsson U, Gudnason V, Thorgeirsson G, Fingerle J, Gurney M, Gudbjartsson D, Frigge ML, Kong A, Stefansson K, Gulcher JR. 2003. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 35:131-138.
71. Grossmann R, Geisen U, Merati G, Mûllges W, Schambeck CM, Walter U, Schwender S. 2002. Genetic risk factors in young adults with, cryptogenic' ischemic cerebrovascular disease. Blood Coagul Fibrinolysis 13:583-590.
72. Hankey GJ, Eikelboom JW. 2001. Homocysteine and stroke. Curr Opin Neurol 14:95-102.
73. Hankey GJ, Eikelboom JW. 2005. Homocysteine and stroke. Lancet 36:194-196.
74. Hassan A, Markus HS. 2000. Genetics and ischaemic stroke. Brain 123:1784-1812.
75. Hassan A, Gormley K, O'Sullivan M, Knight J, Sham P, Vallance P, Bamford J, Markus H. 2004. Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35:654-659.
76. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir M, Frigge ML, Topol EJ, Kong A, Gudnason V, Hakonarson H, Gulcher JR, Stefansson K. 2004. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36:233-239.
77. Helgadottir A, Gretarsdottir S, St. Clair D, Manolescu A, Cheung J, Thorleifsson G, Pasdar A, Grant FA, Whalley LJ, Hakonarson H, Thorsteindottir U, Kong A, Gulcher J, Stefansson K, MacLeod MJ. 2005. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 76:505-509.
78. Heywood DM, Carter AM, Catto AJ, Bamford JM, Grant PJ. 1997. Polymorphisms of the factor VII gene and circulating FVII: C levels in relation to acute cerebrovascular disease and post stroke mortality. Stroke 28:816-821.
79. Hindorff LA, Schwartz SM, Siscovick DS, Psaty BM, Longstreth WT, Jr, Reiner AP. 2002. The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women. J Cardiovasc Risk 9:131-137.
80. Homocysteine Studies Collaboration. 2002. Homocysteine and risk of ischemic heart disease and stroke. JAMA 288:2015-2022.
81. Honda S, Honda Y, Bauer B, Ruan C, Kunicki TJ. 1995. The impact of three dimensional structure on the expression of PlA alloantigen on human integrin beta 3. Blood 86:234-242.
82. Hou L, Osei -Hyiaman D, Yu H, Ren Z, Zhang Z, Wang B, Harada S. 2001. Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients. Neurology 56:490-496.
83. Hsieh K, Funk M, Schillinger M, Endler G, Janisiw M, Reisinger M, Unger P, Greisenegger S, Lang W, Lalouschek W, Mannhalter C. 2004. Vienna Stroke Registry. Impact of the platelet glycoprotein Ib alpha Kozak polymorphism on the risk of ischemic cerebrovascular events: a case-control study. Blood Coagul Fibrinolysis 15:469-473.
84. Huang Q, Liu YH, Yang QD, Xiao B, Ge L, Zhang N, Xia J, Zhang L, Liu ZJ. 2006. Human serum paraoxonase gene polymorphisms, Q192R and L55 M, are not associated with the risk of cerebral infarction in Chinese Han population. Neurol Res 28:549-554.
85. Hutter CM, Austin A, Humpries SE. 2004. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview. Am J Epidemiol 160:430-435.
86. Imai Y, Morita H, Kurihara H, Sugiyama T, Kato N, Ebihara A, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Yazaki Y. 2000. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic disease. Atherosclerosis 149:435-442.
87. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS. 2003. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 34:1364-1369.
88. Jood K, Ladenvall P, Tjarnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, Blomstrand C, Jern C. 2005. Fibrinolytic gene polymorphism and ischemic stroke. Stroke 36:2077-2081.
89. Juul K, Tybjćrg-Hansen A, Steffensen R, Kofoed S, Jensen G, Nordestgaard BG. 2002. Factor V Leiden: the Copenhagen City Heart Study and 2 meta-analyses. Blood 100:3-10.
90. Kalafatis M, Rand MD, Mann KG. 1994. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269:31869-31880.
91. Kanaji T, Okamura T, Osaki K, Kuroiwa M, Shimoda K, Hamasaki N, Niho Y. 1998. A common gene polymorphism (46 C to T substitution) in the 5′ untranslated region of the coagulation factor XII gene is associated with low translation efficacy and decrease in plasma factor XII level. Blood 91:2010-2014.
92. Karagiannis A, Balaska K, Tziomalos K, Gerasimidis T, Karamanos D, Papayeoryiou A, Zamboulis C. 2004. Lack of an association between angiotensin converting enzyme gene polymorphism and peripheral arterial occlusive disease. Vasc Med 9:189-192.
93. Kaushal R, Pal P, Alwell K, Haverbusch M, Flaherty M, Moomaw C, Sekar P, Kissela B, Kleindorfer D, Chakraborty R, Broderick J, Deka R, Woo D. 2007. Association of ALOX5AP with ischemic stroke: a population-based case-control study. Hum Genet 121:601-607.
94. Kelly PJ, Rosand J, Kistler JP, Shih VE, Silvera S, Plomaritoglou A, Furie KL. 2002. Homocysteine, MTHFR 677C- < T polymorphism, and risk of ischemic stroke. Results of a meta-analysis Neurology 59:529-536.
95. Kessler C, Spitzer C, Stauske D, Mende S, Stadlmuller J, Walther R, Rettig R. 1997. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol 17:2880-2884.
96. Kohler HP, Ariens RA, Whitaker P, Grant PJ. 1998. A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost 80:704.
97. Kolovou GD, Daskalova DCh, Hatzivassiliou M, Yiannakouris N, Pilatis ND, Elisaf M, Mikhailidis DP, Cariolou MA, Cokkinos DV. 2003. The epsilon 2 and 4 alleles of apolipoprotein E and ischemic vascular events in the Greek population - implications for the interpretation of similar studies. Angiology 54:51-58.
98. Komitopoulou A, Platokouki H, Kapsimali Z, Pergantou H, Adamtziki E, Aronis S. 2006. Mutations and polymorphisms in genes affecting hemostasis proteins and homocysteine metabolism in children with arterial ischemic stroke. Cerebrovasc Dis 22:13-20.
99. Kuhlenbaumer G, Berger K, Huge A, Lange E, Kessler C, John U, Funke H, Nabavi DG, Stogbauer F, Ringelstein EB, Stoll M. 2006. Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort. J Neurol Neurosurg Psychiatry 77:521-524.
100. Kuijpers R, Faber NM, Cuypers H, Ouwehand WH, von dem Borne AE. 1992. NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine 145 amino acid polymorphism which is associated with the HPA-2 (Ko)alloantigens. J Clin Invest 89:381-384.
101. Kunicki TJ. 2001. The role of platelet collagen receptor (glycoprotein Ia/IIa; integrin alpha2 beta1) polymorphisms in atherothrombotic disease. Curr Opinion Haematol 8:277-285.
102. Lacquemant C, Gaucher C, Delorme C, Chatellier G, Galois Y, Rodier M, Passa P, Balkau B, Mazurier C, Marre M, Froguel P. 2000. Association between high von Willebrand factors levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group. Kidney Int 57:1437-1443.
103. Lalouschek W, Schillinger M, Hsiek K, Endler G, Tentschert S, Lang W, Cheng S, Mannhalter C. 2005. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke 36:1405-1409.
104. Lalouschek W, Endler G, Schillinger M, Hsieh K, Lang W, Cheng S, Bauer P, Wagner O, Mannhalter C. 2007. Candidate genetic risk factors of stroke: results of a multilocus genotyping assay. Clin Chem 53:600-605.
105. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, Despres JP. 1996. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 94:273-278.
106. Lane DA, Grant PJ. 2000. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95:1517-1532.
107. Lanni F, Santulli G, Izzo R, Rubattu S, Zanda B, Volpe M, Iaccarino G, Trimarco B. 2007. The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. J Hypertens 25:551-556.
108. Linnebank M, Montenarh M, Kölsch H, Linnebank A, Schnez K, Schweichel D, Pohl C, Urbach H, Heun R, Harbrecht U, Klockgether T, Wüllner U. 2005. Common genetic variants of homocysteine metabolism in ischemic stroke: a case-control study. Eur J Neurol 12:614-618.
109. Lõhmussaar E, Gschwendtner A, Mueller JC, Org T, Wichmann E, Hamann G, Meitinger T, Dichgans M. 2005. AloX5Ap gene and the PDE4D gene in a central European population of stroke patients. Stroke 36:731-736.
110. MacLeod MJ, Dahiyat MT, Cumming A, Meiklejohn D, Shaw D, St. Clair D. 1999. No association between Glu/Asp polymorphism of NOS3 gene and ischemic stroke. Neurology 53:418-420.
111. Mahley RW, Rall SC. 2000. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507-537.
112. Markus H. 2004. Genes for stroke. J Neurol Neurosurg Psychiatry 75:1229-1231.
113. Martinez-Gonzalez NA, Sudlow CL. 2006. Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 77:1329-1335.
114. Mattu RK, Needham EWA, Morgan R, Rees A, Hackshaw AK, Stocks J, Elwood PC, Galton DJ. 1994. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb 14:1090-1097.
115. McCarron M, Delong D, Alberts M. 1999. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 53:1308-1311.
116. Meharabian M, Allayee H, Wong J, Shih W, Wang XP, Shaposhnik Z, Funk CD, Lusis AJ. 2002. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 91:120-126.
117. Meiklejohn DJ, Vickers MA, Morrison ER, Dijkhuisen R, Moore I, Urbaniak SJ, Greaves M. 2001. In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib. Br J Haematol 112:621-631.
118. Meschia JF, Brott TG, Brown RD. 2005a. Genetics of cerebrovascular disorders. Mayo Clin Proc 80:122-132.
119. Meschia JF, Brott TG, Brown RD, Crook R, Worrall BB, Kissela B, Brown M, Rich S, Case LD, Evans EW, Hague S, Singleton A, Hardy J, on behalf of the SWISS, ISGS and MSGD Investigators. 2005b. Phosphodiesterase 4D and 5-lypoxygenase activating protein in ischemic stroke. Ann Neurol 58:351-361.
120. Morrison AC, Ballantyne CM, Bray M, Chambless LE, Sharrett AR, Boerwinkle E. 2002. LPL polymorphism predicts stroke risk in men. Genet Epidemiol 22:223-242.
121. Moshfegh K, Wuillemin WA, Redondo M, Lämmle B, Beer JH, Liechti-Gallati S, Meyer BJ. 1999. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 353:351-354.
122. Myllykangas L, Polvilkoski T, Sulkava R, Notkota IL, Rastas S, Verkoniemi A, Tienari PJ, Niinisto L, Hardy J, Perez-Tur J, Kontula K, Haltia M. 2001. Association of lipoprotein lipase Ser 447Ter polymorphism with brain infarction: a population-based neuropathological study. Ann Med 33:486-492.
123. Nakayama T, Asai S, Sato N, Soma M. 2006. Genotype and haplotype association study of the STRK1 region on 5q12 among Japanese: a case-control study. Stroke 37:69-76.
124. Nikolopoulos GK, Tsantes AE, Bagos PG, Travlou A, Vaiopoulos G. 2007. Integrin, alpha 2 gene C807 T polymorphism and risk of ischemic stroke: a meta-analysis. Thromb Res 119:501-510.
125. Nilsson-Ardnor S, Wiklund P-G, Lindgren P, Nilsson AK, Janunger T, Escher SA, Hallbeck B, Stegmayr B, Asplund K, Holmberg D. 2005. Linkage of ischemic stroke to the PDE4D region on 5q in a Swedish population. Stroke 36:1666-1671.
126. Nowak-Gottl U, Strater R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein. 1999. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 94:3678-3682.
127. Nowak-Gottl U, Strater R, Kosch A, von Eckadstein A, Schobess R, Luigs P, Nabel P, Vielhaber H, Kurnik K, Junker R. 2001. The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group. Eur J Haematol 66:57-62.
128. Oguchi S, Ito D, Murata M, Yoshida T, Tananashi N, Fukuuchi Y, Ikeda Y, Watanabe K. 2000. Genotype distribution of the 46C/T polymorphism of coagulation factor XII in the Japanese population: absence of its association with ischemic cerebrovascular disease. Thromb Haemost 83:178-179.
129. Oksala NK, Heikkinen M, Mikkelsson J, Pohjasvaara T, Kaste M, Erkinjuntti T, Karhunen PJ. 2007. Smoking and the platelet fibrinogen receptor glycoprotein IIb/IIIA PlA1/A2 polymorphism interact in the risk of lacunar stroke and midterm survival. Stroke 38:50-55.
130. Pasdar A, Ross-Adams H, Cumming A, Cheung J, Whalley L, St. Clair D, Macleod M-J. 2006. Paraoxonase gene polymorphisms and haplotype analysis in a stroke population. BMC Med Genet 7:28.
131. Pera J, Slowik A, Dziedzic T, Wloch D, Szczudlik A. 2006. ACE I/D polymorphism in different etiologies of ischemic stroke. Acta Neurol Scand 114:320-322.
132. Petrovic D, Milanez T, Kobal J, Bregar D, Potisk KP, Peterlin B. 2003. Prothrombotic gene polymorphisms and atherothrombotic cerebral infarction. Acta Neurol Scand 108:109-113.
133. Pezzini A, Grassi M, Del Zotto E, Bazzoli E, Archetti S, Assanelli D, Akkawi NM, Albertini A, Padovani A. 2004. Synergistic effect of apolipoprotein E polymorphisms and cigarette smoking on risk of ischemic stroke in young adults. Stroke 35:438-442.
134. Pezzini A, Grassi M, Iacoviello L, Del Zotto E, Archetti S, Giossi A, Padovani A. 2007. Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives. J Neurol Neurosurg Psychiatry 78:271-276.
135. Pfohl M, Fetter M, Koch M, Barth CM, Rudiger W, Häring HU. 1998. Association between angiotensin I-converting enzyme genotypes, extracranial artery stenosis, and stroke. Atherosclerosis 140:161-166.
136. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. 1996. A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated to an elevated plasma prothrombin level and an increase in venous thrombosis. Blood 88:3698-3703.
137. Qureshi AI, Giles WH, Croft JB, Guterman LR, Hopkins LN. 2002. Apolipoproteins A-1 and B and the likelihood of non-fatal stroke and myocardial infarction-data from The Third National Health and Nutrition Examination Survey. Med Sci Monit 8:CR311-CR316.
138. Ranade K, Kirchgessner TG, Iakoubova OA, Devlin JJ, DelMonte T, Vishnupad P, Hui L, Tsuchihashi Z, Sacks FM, Sabatine MS, Braunwald E, White TJ, Shaw P, Dracopoli NC. 2005. Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke 36:2346-2350.
139. Reid IA. 1998. The renin-angiotensin system: physiology, pathophysiology, and pharmacology. Adv Physiol Educ 275:236-245.
140. Reiner AP, Kumar PN, Schwartz SM, Longstreth WT, Jr, Pearce RM, Rosendaal FR, Psaty BM, Siscovick DS. 2000. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 31:1628-1633.
141. Reiner AP, Siscovick DS, Rosendaal FR. 2001a. Hemostatic risk factors and arterial thrombotic disease. Thromb Haemost 85:584-595.
142. Reiner AP, Siscovick DS, Rosendaal FR. 2001b. Platelet glycoprotein gene polymorphisms and risk of thrombosis: facts and fancies. Rev Clin Exp Hematol 5:262-287.
143. Reiner AP, Frank MB, Schwartz SM, Linenberger ML, Longstreth WT, Teramura G, Rosendaal FR, Psaty BM, Siscovick DS. 2002. Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women. Br J Haematol 116:376-382.
144. Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. 1997. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 349:385-388.
145. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. 1990. An insertion/deletion polymorphism in angiotensin I converting enzyme gene accounting for half of the variance of the serum enzyme levels. J Clin Invest 86:1434-1436.
146. Roest M, van der Schouw YT, Banga jD, Tempelman MJ, de Groot PG, Sixma JJ, Grobbee DE. 2000. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation 101:67-70.
147. Rosand J, Altshuler D. 2003. Human genome sequence variation and the search for genes influencing stroke. Stroke 34:2512-2517.
148. Rosand J, Bayley N, Rost N, de Bakker PI. 2006. Many hypotheses but no replication for the association between PDE4D and stroke. Nat Genet 38:1091-1092.
149. Rubattu S, Giliberti R, Volpe M. 2000. Etiology and pathophysiology of stroke as a complex trait. Am J Hypertens 13:1139-1148.
150. Rubattu S, Di Angelantonio E, Nitsch D, Gigante B, Zanda B, Stanzione R, Evangelista A, Pirisi A, Rosati G, Volpe M. 2005. Polymorphism in prothrombotic genes and their impact on ischemic stroke in a Sardinian population. Thromb Haemost 93:1095-1100.
151. Saleheen D, Bukhari S, Haider SR, Nazir A, Khanum S, Shafqat S, Anis MK, Frossard P. 2005. Association of phosphodiesterase 4D gene with ischemic stroke in a Pakistani population. Stroke 36:2275-2277.
152. Santamaria A, Mateo J, Tirado I, Oliver A, Belvis R, Marti-Fabregas J, Felices R, Soria JM, Souto JC, Fontcuberta J. 2004. Homozygosity of the T allele of the 46 C- > T polymorphism in the F12 gene is a risk factor for ischemic stroke in the Spanish population. Stroke 35:1795-1799.
153. Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A. 1999. Association of the platelet glycoprotein Ia C807 T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 93:2449-2453.
154. Sazci A, Ergul E, Tuncer N, Akpinar G, Kara I. 2006. Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: dual effect of MTHFR polymorphisms C677 T and A1298C. Brain Res Bull 71:45-50.
155. Schmidt H, Schmidt R, Niederkorn K, Horner S, Becsagh P, Reinhart B, Schumacher M, Weinrauch V, Kostner GM. 1998a. Beta-fibrinogen gene polymorphism (C148- > T) is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Arterioscler Thromb Vasc Biol 18:487-492.
156. Schmidt H, Schmidt R, Niederkorn K, Gradert A, Schumacher M, Watzinger N, Hartung HP, Kostner GM. 1998b. Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Stroke 29:2043-2048.
157. Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, Dilley RB, Loskutoff DJ. 1992. Increased type I plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 89:6998-7002.
158. Sethi AA, Tybjaerg-Hansen A, Gronholdt MLM, Steffensen R, Schnohr P, Nordestgaard BG. 2001. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study. Ann Intern Med 134:941-954.
159. Shimo-Nakanishi Y, Urabe T, Hattori N, Watanabe Y, Nagao T, Yokochi M, Hamamoto M, Mizuno Y. 2001. Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese. Stroke 32:1481-1486.
160. Sirachainan N, Tapanapruksakul P, Visudtibhan A, Chuansumrit A, Cheeramakara C, Atamasirikul K, Chotsuppakarn S, Areekul S. 2006. Homocysteine, MTHFR C677 T, vitamin B12, and folate levels in Thai children with ischemic stroke: a case-control study. J Pediatr Hematol Oncol 28:803-808.
161. Sirgo G, Perez-Vela JL, Morales P, Del Rey M, Vendrell J, Gutierrez C, Rello J. 2006. Association between 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene with stroke or encephalopathy after cardiac surgery. Intensive Care Med 32:668-675.
162. Slooter AJ, Rosendaal FR, Tanis BC, Kemmeren JM, van der Graaf Y, Algra A. 2005. Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. J Thromb Haemost 3:1213-1217.
163. Slowik A, Dziedzic T, Turaj W, Pera J, Glodzik-Sobanska L, Szermer P, Malecki MT, Figlewicz DA, Szezudlik A. 2004. A2 allele of GpIIIa gene is a risk factor for stroke caused by large-vessel disease in males. Stroke 35:1589-1593.
164. Slowik A, Dziedzic T, Pera J, Figlewicz DA, Szezudlik A. 2005. Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage. Cerebrovasc Dis 19:165-170.
165. Song Q, Cole JW, O'Connell JR, Stine OC, Gallagher M, Giles WH, Mitchell BD, Wozniak MA, Stern BJ, Sorkin JD, McArdle PF, Naj AC, Xu Q, Gibbons GH, Kittner SJ. 2006. Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study. Hum Mol Genet 15:2468-2478.
166. Sonoda A, Murata M, Ito D, Tanahashi N, Ohta A, Tada Y, Takeshita E, Yoshida T, Saito I, Yamamoto M, Ikeda Y, Fukuuchi Y, Watanabe K. 2000. Association between platelet glycoprotein Ibalpha genotype and ischemic cerebrovascular disease. Stroke 31:493-497.
167. Sonoda A, Murata M, Ikeda Y, Fukuuchi Y, Watanabe K. 2001. Stroke and platelet glycoprotein Iba polymorphisms. Thromb Haemost 85:573-574.
168. Souza DRS, Campos BF, Arruda EF, Yamamoto LJ, Trindade DM, Tognola WA. 2003. Influence of the polymorphism of apolipoprotein E in cerebral vascular disease. Arq Neuropsiquiatr 61:7-13.
169. Spanbroek R, Gräbner R, Lötzer K, Hildner M, Urbach A, Rühling K, Moos MP, Kaiser B, Cohnert TU, Wahlers T, Zieske A, Plemz G, Robenek H, Salbach P, Kühn H, Samulesson B, Habenicht AJR. 2003. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 100:1238-1243.
170. Staton JM, Sayer MS, Hankey GJ, Thakkinstian A, Yi Q, Cole VJ, Baker R, Eikelboom JW. 2006. Association between phosphodiesterase 4D gene and ischaemic stroke. J Neurol Neurosurg Psychiatr 77:1067-1069.
171. Sturgeon JD, Folsom AR, Bray MS, Boerwinkle E, Ballantyne CM, for the Atherosclerosis Risk in Communities Study Investigators. 2005. Apolipoprotein E genotype and incident ischemic stroke: the atherosclerosis risk in communities study. Stroke 36:2484-2486.
172. Sudlow C, Martinez Gonzalez NA, Kim J, Clark C. 2006. Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. Stroke 37:364-370.
173. Sykes TCF, Fegan C, Mosquera D. 2000. Thrombophilia, polymorphisms, and vascular disease. Mol Pathol 53:300-306.
174. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L. 2001. Evaluation of the roles of the Leiden V mutation and ACE I/D polymorphism in subtypes of ischaemic stroke. J Neurol 248:756-761.
175. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L. 2002. Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol 249:1391-1397.
176. Szolnoki Z, Somogyvari F, Kondacs A, Szabo M, Fodor L, Bene J, Melegh B. 2003. Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke. J Neurol Neurosurg Psychiatry 74:1615-1620.
177. Szolnoki Z, Havasi V, Bene J, Komlosi K, Szöke D, Somogyvari F, Kondacs A, Szabo M, Fodor L, Gati I, Wittman I, Melegh B. 2005. Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke. Acta Neurol Scand 111:29-33.
178. Thogersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F, Hallmans G. 1998. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 98:2241-2247.
179. Thorn JA, Chamberlain JC, Alcolado JC, Oka K, Chan L, Stocks J, Galton DJ. 1990. Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis 85:55-60.
180. Tirado I, Soria JM, Mateo J, Oliver A, Souto JC, Santamaria A, Felices R, Borrell M, Fontcuberta J. 2004. Association after linkage analysis indicates that homozygosity for the 46C- > T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis. Thromb Haemost 91:899-904.
181. Tuncer N, Tuglular S, Kilic G, Sazci A, Us O, Kara I. 2006. Evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischaemic stroke. J Clin Neurosci 13:224-227.
182. Ueno T, Shimazaki E, Matsumoto T, Watanabe H, Tsunemi A, Takahashi Y, Mori M, Hamano R, Fujioka T, Soma M, Matsumoto K, Kanmatsuse K. 2003. Paraoxonase 1 polymorphism Leu-Met55 is associated with cerebral infarction in Japanese population. Med Sci Monit 9:260-264.
183. van Goor MPJ, Gomez-Garcia EB, Leebek FWG, Brouwers GJ, Koudstaal PJ, Dippel DWJ. 2005. The -148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case-control study. J Neurol Neurosurg Psychiatry 76:121-123.
184. van Rijn MJE, Slooter AJC, Seht AFC, Isaacs A, Aulchenko YS, Snijders PJLM, Kappelle LJ, van Swieten JC, Oostra BA, van Duijn CM. 2005. Familial aggregation, the PDE4D gene, and ischemic stroke in a genetically isolated population. Neurology 65:1203-1209.
185. van Rijn MJ, Bos MJ, Isaacs A, Yazdanpanah M, Arias-Vasquez A, Stricker BH, Klungel OH, Oostra BA, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM, van Duijn CM. 2007. Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology. J Neurol Neurosurg Psychiatry 78:1083-1087.
186. Varda NM, Peterlin B, Bradac SU, Gregari A. 2005. Carotid artery intima-media thickness and angiotensin-converting enzyme gene polymorphism in the offspring of parents with premature stroke. Acta Paediatr 94:33-37.
187. Voetsch B, Benke KS, Damasceno BP, Siqueira LH. 2002. Paraoxonase 92 Gln- > Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke 33:1459-1464.
188. Voetsch B, Benke KS, Panhuysen CI, Damasceno B, Loscalzo J. 2004. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults. Arch Neurol 61:351-356.
189. Wald DS, Law M, Morris JK. 2002. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325:1-7.
190. Walldius G, Aastveit AH, Jungner I. 2006. Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study. J Intern Med 259:259-266.
191. Wang XL, McCredie RM, Wilcken DEL. 1996. Common DNA polymorphisms at lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. Circulation 93:1339-1345.
192. Wang WY, Barratt BJ, Clayton DG, Todd JA. 2005. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 6:109-118.
193. Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661-678.
194. Wiklund PG, Nilsson L, Ardnor SN, Eriksson P, Johansson L, Stegmayr B, Hamsten A, Holmberg D, Asplund K. 2005. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts. Stroke 36:1661-1665.
195. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. 1984. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311:501-505.
196. Wittrup HH, Nordestgaard BG, Sillesen H, Schnohr P, Tybjćrg-Hansen A. 2000. A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men. Circulation 101:2393-2397.
197. Worrall BB, Mychaleckyj JC. 2006. PDE4D and stroke: a real advance or a case of the emperor's new clothes? Stroke 37:1955-1977.
198. Wu AH, Tsongalis GJ. 2001. Correlation of polymorphism to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol 87:1361-1366.
199. Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP, et al. 1995. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study (Etude CasTemoins de l'Infarctus du Myocarde). Thromb Haemost 74:837-841.
200. Yee DL, Bray PF. 2004. Clinical and functional consequences of platelet membrane glycoprotein polymorphisms. Semin Thromb Hemost 30:591-600.
201. Yeh PS, Lin HJ, Li YH, Lin KC, Cheng TJ, Chang CY, Ke DS. 2004. Prognosis of young ischemic stroke in Taiwan: impact of prothrombotic genetic polymorphism. Thromb Haemost 92:583-589.
202. Zee RY, Brophy VH, Cheng S, Hegener HH, Erlich HA, Ridker PM. 2006a. Polymorphisms of the phosphodiesterase 4D, cAMP-specific (PDE4D) gene and risk of ischemic stroke: a prospective, nested case-control evaluation. Stroke 37:2012-2017.
203. Zee RYL, Cheng S, Hegener HH, Erlich HA, Ridker PM. 2006b. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach. Stroke 37:2007-2011.
204. Zeerleder S, Schloesser M, Redondo M, Wuillemin WA, Engel W, Furlan M. 1999. Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency - a study on 73 subjects from 14 Swiss families. Thromb Haemost 82:1240-1246.
205. Zhang JH, Kohara K, Yamamoto Y, Nakura J, Tabara Y, Fujisawa M, Katagi R, Miki T. 2004. Genetic predisposition to neurological symptoms in lacunar infarction. Cerebrovasc Dis 17:273-279.
206. Zhang Y, Wang Y, Cui C, Hiang P, Li X, Liu S, Lendon C, Guo N. 2007. Platelet glycoprotein polymorphisms: risk, in vivo expression and severity of atherothrombotic stroke in Chinese. Clin Chim Acta 378:99-104.
207. Zhao SP, Tong QG, Xiao ZJ, Cheng YC, Zhou HN, Nie S. 2003. The lipoprotein lipase Ser447Ter mutation and risk of stroke in the Chinese. Clin Chim Acta 330:161-164.
208. Zito F, Lowe GD, Rumley A, McMahon AD, Humphries SE, WOSCOPS Study Group West of Scotland Coronary Prevention Study. 2002. Association of the factor XII 46C > T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study. Atherosclerosis 165:153-158.